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RESUMEN
La saliva es la primera barrera para la entrada de bacterias y
virus en el cuerpo. Las glándulas submandibulares (GSM) con­
tribuyen al mantenimiento de la salud oral y a la regulación de
las respuestas inmuno­inflamatorias. Estudios previos sugieren
que el factor de crecimiento transformante beta 1 (TGFB1) puede
contribuir a la fibrosis de las glándulas salivales, pero la expre­
sión y localización del sistema TGFB1 en las GSM no ha sido
dilucidada. El objetivo del presente trabajo fue analizar por
inmuno­histoquímica en las GSM de ratas la expresión de TGFB1
y sus receptores específicos ALK5 (pro­fibrótico) y ALK1 (pro­
proliferativo) y el co­receptor endoglina (EDG) en un modelo de
periodontitis bilateral experimental (PE) (hilo de algodón alrede­
dor del cuello de los primeros molares inferiores) durante 1 y 6
semanas. Las GSM fueron fijadas y embebidas en parafina para
realizar cortes seriados los cuales se tiñeron con hematoxilina­
eosina para analizar la histología o se procesaron para realizar
la técnica de inmunohistoquímica mediante detección con
diaminobenzidine. La histología de las GSM de animales con PE
reveló cambios estructurales tiempo dependientes, con una mar­
cada reducción de la altura de los conductos, destrucción celu­
lar, pérdida de gránulos secretores, congestión periductal y exce­
so de tejido conectivo que rodea los conductos, indicando un pro­
ceso de fibrosis respecto de las GSM de animales control. TGFB1,
ALK5 y ALK1 y el co­receptor EDG fueron principalmente
inmunolocalizados en las células que forman los ductos y en las
áreas de fibrosis en los grupos con PE. La expresión del receptor
pro­fibrótico ALK5 se incrementó en las áreas de fibrosis en GSM
de animales con PE. En GSM de ratas con PE, la localización de
los receptores específicos de TGFB1 en las células de los con­
ductos y áreas de fibrosis, junto con la expresión de TGFB1 en
las áreas circundantes, podría indicar acciones paracrinas y
autocrinas ejercidas por TGFB1 a través de sus receptores
específicos. Los resultados de este estudio sugieren que TGFB1
podría inducir un proceso de fibrosis promoviendo la prolif­
eración celular a través de los receptores ALK1 y EDG, y favore­
ciendo procesos relacionados con la fibrosis a través de su
receptor ALK5, lo que conduciría a una actividad secretora anor­
mal de la GSM durante la enfermedad periodontal.
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ABSTRACT
Saliva is the first barrier to entry of bacteria and viruses into 
the body. The submandibular glands (SMG) contribute to 
the maintenance of oral health and regulation of immune/
inflam matory responses. Previous studies suggest that
transforming growth factor beta 1 (TGFB1) may contribute to
salivary gland fibrosis but the expression of the TGFB1 system
in the SMG has not been elucidate. Thus, the aim of this study
was to analyze in rat SMG the immunolocalization of TGFB1
and its specific receptors ALK5 (pro­fibrotic) and ALK1 (pro­
proliferative) and the co­receptor endoglin (EDG) in a bilateral
experimental periodontitis (EP) model (cotton thread ligature
around the neck of the first lower molars) for 1 and 6 weeks.
Fixed SMG were embedded in paraffin and serially cut 
for routine hematoxylin–eosin staining for histological analysis
or immunohistochemical techniques by diaminobenzidine
detection. SMG histology from animals with EP showed time­
dependent structural changes involving marked reduction in the
height of the contoured ducts, cell destruction, loss of secretory
granules, periductal congestion and excess connective tissue
surrounding these ducts indicative of a fibrotic process,
compared to control SMG. TGFB1, ALK5 and ALK1 receptors
and the co­receptor EDG were mainly immunolocalized in
ductal cells and in the fibrotic areas in EP groups. The
expression of the pro­fibrotic ALK5 receptor was increased in
areas of fibrosis in SMG of animals with EP. In SMG of rats
with EP, the localization of the TGFB1 specific receptors in the
ducts and cells from fibrotic areas, due to the expression of
TGFB1 in the surrounding areas, might indicate paracrine and
autocrine actions exerted by TGFB1 via its specific receptors.
The results of this study suggest that TGFB1 promotes fibrosis,
inducing cell proliferation via ALK1 and EDG receptors and
stimulates fibrosis related­processes via ALK5 receptor, which
could lead to abnormal secretor activity of the SMG during
periodontal disease. 
Key words: Submandibular gland, Transforming Growth
Factor beta1, Activin Receptors, Fibrosis, Periodontitis.
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INTRODUCTION
Periodontal diseases have been well described and
characterized according to different degrees of
inflammation, eventually leading to the destruction
of teeth­supporting tissue. Periodontitis is characte ­
rized by chronic activation of the immune response
and synthesis of several cytokines and proteases.
Cytokines induce alterations in the cellular
metabolism of the connective tissue concomitant
with the destruction of the periodontal tissue and
tooth loss1. 
The pair of submandibular glands (SMG) is
involved in the maintenance of the oral health and
regulation of immune/inflammatory responses2.
The SMG has a ductal structure that opens into the
oral cavity with secretory end pieces, the mucous and
serous acini, producing saliva3. A time­dependent
link has been observed between experimental
periodontitis (EP) and SMG activity, mediated by
systemic and neural mechanisms. Initially, the EP
stimulates glandular secretion, while the progression
of the disease affects the normal function of the
gland, leading to histological and biochemical
changes, including an inflammatory response and
reduced secretion4,5.
There is growing evidence showing the relationship
between cytokines and the pathological fibrotic
process of different tissues, characterized by the
development of excess fibrous connective tissue, as
a consequence of a tissue repair process that triggers
an increase in the production and deposition of
extracellular matrix. Among these cytokines, the
transforming growth factor beta 1 (TGFB1) plays
an important role. The TGFB1 inhibitory and
stimulatory properties have been described in the
regulation of cellular homeostasis in both
physiological and pathological stages6­9. The effects
of TGFB1 are exerted via specific type I and type II
serine/threonine kinase receptors. Type II receptor
(TGFBRII) transphosphorylates and activates type
I receptor (TGFBRI). Two TGFBRI have been
described: activin receptor­like kinase 1 (ALK1),
which signals via phosphorylation of Smads 1/5,
and activin receptor­like kinase 5 (ALK5), which
signals via phosphorylation of Smads 2/310. In line
with this, endoglin (EDG) appears to be a key co­
receptor that contributes to an efficient transduction
pathway of ALK­111. In this context, it has been
observed that deregulation mechanisms of TGFB1
appear to be involved in the progression of diseases
such as cancer and autoimmune fibrosis6. However,
the expression of the TGFB1 system in the SMG
affected by periodontal disease is unknown. The
aim of this study was to analyze the localization of
TGFB1 and its specific receptors ALK5 and ALK1
and the co­receptor EDG in rat SMG after 1 and 6
weeks of EP induction. 
MATERIALS AND METHODS
Animals
Adult male Wistar rats from our own colony with
initial body weight 220­250 g were randomly
divided into 4 groups (n=8 animals per treatment):
(1) 1­ week control, (2) 1­ week bilateral EP, (3) 6­
week control, (4) 6­ week bilateral EP. They were
kept in group cages in an animal room with a
photoperiod of 12 h light (07.00–09.00 h), room
temperature 22–25° C, humidity: 52–56% and fed
standard Purina chow pellets and tap water ad
libitum. All experiments were performed following
the National Institute of Health guidelines for the
care and use of laboratory animals (NIH 85­23,
revised in 1985) and protocols were approved by
the Ethical Commission of the School of Dentistry,
University of Buenos Aires.
Induction of experimental periodontitis
EP was performed as previously reported5. EP was
induced under general anesthesia with a mixture of
2% xylazine hydrochloride (5 mg/kg; i.p.) and 5%
ketamine hydrochloride (50 mg/kg; i.p.). A cotton
thread ligature was placed around the neck of both
first lower molars (bilateral EP) and served as a
retention device for oral microorganisms. The
ligature was pushed into the gingival sulcus and 
left in place until sacrifice (1­ and 6 weeks post
surgery). In the 6 week EP treatment, the thread was
renewed every 2 weeks in order to prevent the
ligature from coming out of the sulcus, thereby not
meeting the desired objective. The SMG and
submandibular lymph nodes were removed and
weighed (mg), after which they were fixed in 4%
PFA for histological and immunohistochemical
studies. 
SMG histology and immunohistochemistry
The tissues mounted in paraffin were cut at 5­µm
sections, dewaxed in xylene and rehydrated in
graded alcohols. For each specimen, at least 3 to 5
slides were stained with hematoxylin/eosin for
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general histological inspection. Two specialists
reviewed all the SMG samples. For immunohisto ­
chemical analysis, endogenous peroxidase activity
was inhibited in tissue sections using 0.5% v/v
H2O2/methanol. Sections were blocked for 1 h with
15% normal goat serum in phosphate­buffered
saline (PBS) and then incubated overnight at 4°C
with primary antibody (1:100 diluted rabbit anti­
TGFB1, sc­146; 1:100 diluted rabbit anti TGFB RI
[V­22], sc­402; 1:100 diluted rabbit anti TGFB RI
[T­19], sc­398; 1:100 diluted rabbit anti­endoglin,
sc­20632, Santa Cruz Biotechnology, Inc., USA).
After 3 rinses in PBS, sections were incubated for
1h at room temperature with the appropriate 1:200
diluted biotinylated secondary antibody (Vector
Labs, UK). After further washing in PBS, sections
were incubated with 1:100 diluted streptavidin–
peroxidase complexes (ABC kit, Vector Labs, UK).
Development of peroxidase activity was achieved
with 0.05% w/v 3,3­diaminobenzidine and 0.1%
v/v H2O2 in Tris–HCl. Negative controls were
processed simultaneously by omitting the primary
antibody or pre­absorbing the primary antibody
with specific synthetic peptides. 
Statistical Analysis
Mean and standard error (SEM) were calculated
and the InfoStat Software (version 2011, developed
by Statistics Department, National University of
Córdoba) was used for calculating differences
between 2 groups using Student´s t test. A p­value
of less than 0.05 was considered significant. 
RESULTS
Histology of the SMG in rats with bilateral EP 
The weight of the SMG and submandibular lymph
nodes in the EP groups was significantly higher than
control SMG in both 1­ and 6­ week treatments
(p<0.05) (Fig. 1A). The histology of the SMG of
animals with 1­ and 6­ week EP showed alterations
of the epithelial architecture and ducts, partial loss
of material granular secretion and periductal edema, as
well as an excess in the connective tissue surrounding
the ducts, indicative of a fibrotic process compared
to the control SMG (Fig. 1B). 
Detection of TGFB1, ALK5, ALK1 and 
co­ receptor EDG in SMG from rats with EP
TGFB1 and its specific receptors ALK1 and AKL5
and co­receptor EDG were immunolocalyzed in the
cell cytoplasm of the ducts of control SMG and
SMG from animals with 1­ and 6 week EP (Fig. 2).
TGFB1, ALK1 and EDG were localized in the
apical zone and nearest to the lumen while ALK5
showed diffuse localization within cell cytoplasm
(Fig. 2). 
The expression of TGFB1 and its specific receptors
was also predominantly detected in the cytoplasm
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Fig. 1: Weight of SMG and submandibular lymph nodes (A)
and general histology of SMG (B) in animals with 1­ and 6­
week EP. (B) Note the SMG of periodontitis groups with fibrotic
areas surrounding ducts (red arrows). Data are plotted as
mean ± SEM (n=6). *p<0.05 different from control group. EP:
experimental periodontitis; D: duct; MA: mucous acini; SA:
serous acini.
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of cells from the fibrosis areas
surrounding the ducts in the
affected SMG from animals
with 1­ and 6­ week EP (Fig. 2).
TGFB1 was also detected in
mucous acinus (MA) and
predo minantly observed only
in SMG of EP groups. Con ­
cerning the expression of
ALK5, most of the cells from
fibrosis areas were immuno ­
positive for this receptor in
animals with 6­ week EP
while the localization of
ALK5 was detected in cell
clusters in animals with 1­
week EP (Fig. 2). Serous acinus
(SA) showed no immunos ­
taining for ALK5 and only 
a few immunopositive MA 
were observed in SMG from
all treatment groups. The
expression of ALK1 and its
co­receptor EDG was mainly
observed in cells of fibrosis
areas with intense immunos ­
taining in the affected SMG
from animals with 1­ and 
6­week EP (Fig. 2). Some
immuno positive MA for
ALK1 and EDG was observed
in the SMG from EP treatment
groups.
DISCUSSION
TGFB1, a pro­fibrotic cytokine, participates in
diverse biological processes including inflamma­
tion, fibrosis, tissue regeneration and epithelial­
mesenchymal transition6,12­15In this study, we 
followed the expression of TGFB1 and its specific
receptors ALK5 and ALK1 and the co­receptor
EDG in normal SMG and in SMG after 1 and 6
weeks of induction of EP in adult rats. To our
knowledge, this is the first report of global analysis
of the expression of the TGFB1 system in SMG in
EP conditions. 
Normal SMG secretor activity is essential because
saliva is the first barrier to entry of bacteria into the
body, so changes in secretion are important in the
onset and progression of oral infectious processes16.
Using a 1­ and 6­ week EP model, we observed
histological changes in the SMG, mainly including
the appearance of large fibrotic areas that could
affect the normal secretor function of the gland. We
detected alterations of the epithelial architecture and
the ducts, partial loss of material granular secretion
and excess in the connective tissue surrounding the
ducts indicative of a fibrotic process in SMG after
induction of EP. Moreover, SMG and lymph nodes
weighed more in animals with EP than in control
animals regardless of the duration of the treatment.
This may be explained by the fact that EP produced
severe structural changes involving a marked
reduction in the height of the granular convoluted
ducts, cell destruction, loss of secretory granules,
increased fibrosis and periductal congestion. 
Under these experimental treatments, there is an
excess of immunopositive cells for TGFB1 in the
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Fig. 2: Immunolocalization of the TGFB1 system in SMG from animals with 1­ and 6­
week EP. Note that fibrotic areas (red arrows) of the SMG of periodontitis groups are
intensively immunostaned with TGFB1. These areas were also immunopositive for ALK5
and ALK1 receptor and co­receptor EDG, particularly, in 6­week EP. EP: experimental
periodontitis; D: duct; MA: mucous acini; SA: serous acini; EDG: endoglin.
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connective tissue surrounding the ducts, indicative
of a fibrotic process. In line with this, Hall et al.17
have reported an increase in TGFB1 expression in
salivary glands leading to hypofunction of the 
tissue due to the replacement of normal glandular
parenchyma with interstitial fibrous tissue. We
recently reported altered function of the SMG,
including partial loss of secretor granular material
with reduced salivary secretion and periductal
oedema in EP treatments5. 
Concerning the type of the TGFB1 receptor, it 
has been shown that the presence of the co­receptor
EDG promotes TGFB1 signaling via ALK1
receptor leading to cell proliferation and attenuates
the ALK5 signaling that leads to cell cycle 
arrest 9,18. There is also growing evidence indicating
that in pathological conditions, TGFB1 stimulates
fibrosis through deposition of extracellular matrix
and epithelial­mesenchymal transition via ALK5
receptor and activation of Smad2/3 19­21. In the
present study, the expression pattern of ALK1 and
its co­receptor EDG was similar and remained
constant in the fibrotic areas of SMG in all EP
treatments. This could indicate that TGFB1
induces a proliferative response in the connective
tissue surrounding the ducts, stimulating the
fibrotic process. In line with this, the quantity of
cells in fibrotic areas expressing ALK5 increased
in SMG concomitant with the days of the EP
treatment, which may reflect a fibrotic process that
becomes more aggressive with the duration of the
periodontitis. 
In conclusion, to our knowledge, this is the first
report of the expression and localization of TGFB1
and its receptors ALK5 and ALK1 and co­receptor
EDG in the SMG. We postulate that TGFB1 would
be a key factor in SMG during periodontitis condi ­
tions, probably stimulating tissue damage, fibrosis
and morphological alterations associated to
abnormal secretor activity. The SMG of animals
with EP appears to be an interesting model for
studying diverse mechanisms that promote gland
fibrosis exerted by TGFB1. Further insights into
TGFB1 signaling in SMG could identify novel
therapeutic targets for salivary gland fibrosis,
whether or not associated to periodontal disease.
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